GlassScriptPhysician profile
Biby Reji
NPI 1841079571
$1,092.78
in general payments reported to CMS, 2019-2025
19 companies · $573 in 2025
The $573 reported for 2025 was more than what 76% of Gerontology (Nurse Practitioner) providers received nationally (typical 2025 total: $180).
See the full distribution for Gerontology (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $55.33 · 2024: $464 · 2025: $573.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,070 · Education: $23.10.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,069.68 |
| Education | $23.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $140.76 | 2024-2025 | |
| Sobi, INC | $122.88 | 2024-2025 | |
| Astrazeneca Pharmaceuticals LP | $115.78 | 2024-2025 | Calquence |
| Syndax Pharmaceuticals, INC. | $99.02 | 2025 | |
| Astellas Pharma US INC | $96.27 | 2024-2025 | Xospata, Cresemba |
| Glaxosmithkline, LLC. | $73.45 | 2024-2025 | Ojjaara |
| Incyte Corporation | $69.53 | 2023-2025 | Jakafi, Niktimvo |
| Celgene Corporation | $64.57 | 2025 | Reblozyl |
| Lilly USA, LLC | $53.57 | 2024 | Jaypirca |
| Novartis Pharmaceuticals Corporation | $33.68 | 2024 | |
| Pfizer INC. | $33.15 | 2024 | |
| Pharmaessentia USA Corporation | $29.87 | 2025 | Besremi |
| Beigene USA, INC. | $28.09 | 2024 | Brukinsa |
| Daiichi Sankyo INC. | $27.66 | 2023 | |
| Janssen Biotech, INC. | $27.54 | 2024 | Imbruvica |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $26.52 | 2024 | Iclusig |
| Invivyd INC | $18.80 | 2024 | Pemgarda |
| Azurity Pharmaceuticals, INC. | $17.14 | 2025 | Danziten |
| Adaptive Biotechnologies Corporation | $14.50 | 2025 | Clonoseq |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Biby Reji listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.